NovaShunt Appoints Key Executives to its Management Team in Medical Affairs and Commercial Operations
By Novashunt Ag, PRNE
December 2nd, 2009
ZUG, Switzerland, December 3 - NovaShunt today announced the appointment of Dr. Pedro Eerdmans as Chief
Medical Officer and Dan Rose as Vice President of Commercial Operations and
member of the Company's Board of Directors.
"I'm very delighted to welcome these two highly seasoned professionals to
our executive management team which signifies NovaShunt's commitment to
building a strong executive leadership team. Together, Dr. Eerdmans and Mr.
Rose bring a wealth of experience and depth of knowledge of clinical research
and commercial operations in the medical device field to NovaShunt", said
Noel L. Johnson, CEO and President. "Our innovative technology platform has
been proven and we are now moving forward with our final clinical studies for
CE marking and preparing for commercialization of our Implantable Automated
Fluid Management System for the treatment of refractory ascites."
As Chief Medical Officer, Pedro Eerdmans will lead NovaShunt's
Clinical Strategy and manage the European clinical team in all markets. Dr.
Eerdmans has extensive experience in Clinical Research and Medical Devices.
Prior to joining NovaShunt, he was Medical Director at Biosensors responsible
for the global clinical program which included more than 12.000 patients post
marketing registries and over 1800 patients regulatory studies. Additionally,
he spent many years with Medtronic holding management positions in Clinical
Research, Ventures and Technology development. Further Pedro Eerdmans has a
PhD in Pharmacology and has more than 5 years hospital experience in
Orthopedics and Urology. Dr. Eerdmans has authored many peer reviewed papers
and holds a patent in the area of wireless pH measurement in the esophagus.
"It is a great opportunity to join NovaShunt in this early stage and build
the clinical evidence for the AFS system. The AFS system will help a patient
population that is in need of a good solution for their refractory ascites.
The AFS system can significantly improve quality of life, decrease
complications and reduce the burden of refractory ascites patients on the
health systems", said Dr. Eerdmans.
As Vice President of Commercial Operations, Dan Rose will have
responsibility for all sales, marketing and business development activities
and will be an active member of NovaShunt's Board of Directors. Mr. Rose
spent the past seven years in a number of leadership positions at Medtronic.
Most recently, he was Marketing Director for the Coronary and Peripheral
Vascular Division in Western Europe. Prior to that, Mr. Rose was Business
Manager of the Vascular Division in the Nordic region. He also co-founded a
medical device company focused on continuous glucose monitoring technology
and spent time working on early stage venture capital opportunities. "I'm
very excited about joining the company. NovaShunt's implantable technology is
robust, with major applications in several growing markets. The company's
first product is unique and has the potential to improve clinical outcomes
and quality of life for many patients suffering from end-stage liver and
heart failure", said Dan Rose.
About the Automated Fluid Shunt (AFS) System
NovaShunt's lead product is a battery powered implantable pump
system designed to remove excess fluid that collects in the abdominal cavity
of patients with advanced liver disease and congestive heart failure. Liver
disease is present in 2% of the Western population and is the only major
cause of death still increasing every year. Congestive Heart Failure is the
fastest growing cardiac disease in the EU and US, also affecting nearly 2% of
the population. At present NovaShunt is collecting clinical data to prepare
for market launch in Europe in 2010.
About NovaShunt
NovaShunt is a privately owned Swiss medical device company
that aims to become the worldwide leader in design, development, manufacture
and marketing of automated implantable pump systems to manage fluid balance
within the body. NovaShunt is focused on areas of unmet clinical need where
its products can significantly improve clinical outcomes, reduce health care
costs and improve patient quality of life.
Contact:
Carina Bossi Suess
Director Marketing&Communications, Investor and Public Relations
+41-78-609-56-49
carina.bossi@novashunt.com
www.novashunt.com
Contact: Carina Bossi Suess, Director Marketing&Communications, Investor and Public Relations, +41-78-609-56-49, carina.bossi at novashunt.com
Filed under Business, Health, Medical Equipment, Personnel Announcements, Workforce Management / Human Resources | Tags: Novashunt Ag, Switzerland, Zug | Comment Below
Related Press Releases U.S. FDA Officials to Speak at RAPS Medical Device Workshop in BrusselsOctober 29th, 2009 ROCKVILLE, Maryland -
The Regulatory Affairs Professionals Society (RAPS), the leading international membership organization for regulatory professionals in the healthcare product sector, will bring together medical device industry experts and regulators from the U.S. Food and Drug Administration (FDA) in Brussels for a workshop on U.S. TD International Welcomes J. Frank Mermoud to its Executive TeamJuly 27th, 2009 WASHINGTON -
Strategic advisory firm TD International is pleased to announce that Mr. J. Frank Mermoud has joined its Executive Team. Mumtalakat Makes Senior AppointmentsJune 15th, 2009 DUBAI, UAE - Bahrain Investment Company Appoints COO, CIO and VP Corporate Development
Bahrain Mumtalakat Holding Company ,the Bahrain-based investment company, today announces three significant senior management appointments to its management team. Joining Mumtalakat as Chief Operating Officer is John Knight, whose role is to bring organizational best practices to Mumtalakat. Clive Sexton Discusses Contracting and Interim Management for ExecutivesJune 9th, 2009 LONDON - In the second of a series of podcasts about radical career changes, Clive Sexton of Impact Executives joins Rob Grimsey and Carol Rosati of Harvey Nash, to discuss contracting and executive interim management. Interim managers are freelance executives who are bought in for a defined period of time. Regulatory Affairs Professionals Society (RAPS) Opens RAPS Europe in BrusselsMay 27th, 2009 ROCKVILLE, Maryland - With new office, conferences, RAPS renews commitment to European regulatory community
The Regulatory Affairs Professionals Society (RAPS), the world's largest international membership organization of regulatory professionals in the medical device, pharmaceutical, and biotechnology sectors, today announced the opening of its European office in Brussels. RAPS Europe will support RAPS programs, events and operations throughout Europe and serve as the organization's base for European operations. SCM World to Broadcast Results of the 2009 AMR Research Supply Chain Top 25May 26th, 2009 LONDON - SCM World (a RaptureWorld Community), the online institute for supply chain, logistics, purchasing, operations and manufacturing executives globally, will interview Kevin O'Marah, AMR Research's Chief Strategy Officer, to discuss the results of the globally recognised 2009 AMR Research Supply Chain Top 25 during a webcast on Thursday 28th May 2009 at 9:00am UK time. Jonathan Bennett, Corporate Director of SCM World, will ask Kevin to explain how the winners are chosen, what the report means for business and what leadership and innovative characteristics the Supply Chain Top 25 demonstrate. Eucomed Survey Shows European Medical Technology Industry is Weathering the Storm but Bracing Itself for Tough TimesMay 18th, 2009 BRUSSELS - Companies "Taking no Chances" - Hospitals Struggling and Price Pressure Increasing
The global economic crisis and recession have shaken many governments and industries. However, a recent survey conducted by Eucomed of 100 top executives at medical technology manufacturers across Europe defies this trend with only 20% of respondents noticing a significant negative impact on their business. Nfocus Neuromedical Appoints Robert O'Holla to Head RegulatoryApril 29th, 2009 PALO ALTO, California - Accomplished regulatory executive enhances Nfocus device development team. Endovascular device start-up Nfocus Neuromedical Inc. Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory AffairsApril 20th, 2009 SOUTHAMPTON, England - Vantia Therapeutics, a company developing novel small molecule drugs targeting large underserved medical markets, today announces the appointment of Rachel Morten as Head of Regulatory Affairs. Rachel has more than 24 years experience in global regulatory affairs and product development in the pharmaceutical and animal health industries. RAPS Offers New International Regulatory Affairs Certification - RAC (GS)April 6th, 2009 ROCKVILLE, Maryland - New RAC Credential Focuses on General Scope of Regulatory Practice, International Standards
The Regulatory Affairs Professionals Society (RAPS) has announced its newest Regulatory Affairs Certification (RAC), the RAC General Scope (GS). The RAC (GS) credential denotes knowledge related to the general scope of practice of regulatory professionals in the healthcare product sector, regardless of geographic location or in which regions they may be involved.
Related News Finance business of GE appoints new CEO for Asia, Pacific regionNovember 24th, 2009 GE Capital appoints new CEO for AsiaNORWALK, Conn. — GE Capital, the financial business of General Electric Co., announced Tuesday the appointment of a new president and CEO of GE Capital's business operations in Asia Pacific. Acting commissioner appointed for Maine's economic development departmentNovember 17th, 2009 Maine appoints economic development chiefAUGUSTA, Maine — Maine's economic development department has a new acting commissioner to take the place of John Richardson, who's resigned to seek the Democratic nomination for governor. Thaxter Trafton was sworn in Monday by Gov. New Mexico legislators propose expanding governing boards for pension, investment fundsDecember 1st, 2009 Lawmakers endorse overhaul of NM investment boardsSANTA FE, N.M. — A legislative panel proposes to overhaul the governing boards of New Mexico's investment and pension funds. Study finds basketball officials tripping over line between fair and foulNovember 23rd, 2009 Foul! Study says basketball refs try to even scoreA study by two professors has found that college basketball referees favor the home team and tend to do what they can to keep foul counts close. The professors, from Indiana University and Ball State, studied 365 college games during the 2004-05 season. Nathan to lead business in ASEAN, India, Hong Kong and TaiwanNovember 19th, 2009 SINGAPORE - Russell Investments today announced the appointment of Mahendran Nathan as Chief Executive of its business in ASEAN*, India, Hong Kong and Taiwan. Nathan will be based in Singapore and will play a key role within the organisation's global leadership team. IIM-C's student executives from manufacturing recruitedNovember 25th, 2009 KOLKATA - Despite the slowdown in the manufacturing sector, all 28 self-sponsored students of the Indian Institute of Management-Calcutta (IIM-C)'s post-graduate programme for executives from that sector have landed campus placements. These students had enrolled for the second Post Graduate Programme for Executives for Visionary Leadership in Manufacturing (PGPEX-VLM). Tata Steel constitutes women's empowerment cellNovember 17th, 2009 RANCHI - Tata Steel has set up a women's empowerment cell, the company said in a statement Tuesday. The cell will ensure that women workers are not discriminated against at work -- especially inside the plant where they are employed as daily wage earners, engineers and executives. Dubai announces restructuring of Dubai WorldNovember 26th, 2009 DUBAI - The government of Dubai has authorised the restructuring of Dubai World to be spearheaded by the Dubai Financial Support Fund (DFSF). The process has begun with the appointment of a Chief Restructuring Officer (CRO). NFL, NFLPA already have jointly approved neurological specialists for about half of teamsNovember 23rd, 2009 NFL, union approve about half team neurologistsWASHINGTON — The NFL and its players union have approved independent doctors to evaluate head injuries for about half of the league's 32 teams as part of a new program. The NFL Players Association medical director, Dr. Playboy appoints men's entertainment veteran to run venerable brand's online contentNovember 30th, 2009 New online chief appointed at PlayboyCHICAGO — Playboy Enterprises Inc. said Monday it has promoted a veteran of the men's entertainment industry and new media platforms to head the brand's newly reorganized online content business.
|
|
